Researchers concluded, “Cannabis use is associated with a reduced risk of elevated fatty liver index in HIV-HCV co-infected patients.”
Search Results for: liver disease
Chapel Hill, NC: Neither the past or current use of cannabis is negatively associated with…
Study: Cannabis Use Associated With Reduced Likelihood Of Liver Cirrhosis Among Hepatitis C Patients
Hepatitis C patients who use cannabis are less likely to contract liver cirrhosis as compared to matched controls…
New York, NY: The administration of the non-psychotropic cannabinoid CBD (cannabidiol) induces selective apoptosis in…
[Editor’s note: This post is excerpted from this week’s forthcoming NORML weekly media advisory. To…
For the better part of ten years NORML (and the ACLU’s Drug Litigation Project) have been 1) monitoring increasing numbers of medical patients denied access to organ transplants for the singular reason that they test positive for cannabis and 2) researching litigation and legislative options to compel organ banks to stop discriminating against medical patients who use cannabis, most especially in states where medical marijuana patients are supposed to be protected by state laws.
After adjusting for confounders, cannabis use was associated with decreased odds of mortality, ICU admission, and pancreatic cancer.
Those who consumed cannabis were at far lower risk of suffering from metabolic disorders.